STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output.

PubWeight™: 45.56‹?› | Rank: Top 0.01% | All-Time Top 1000

🔗 View Article (PMC 434762)

Published in J Clin Invest on December 01, 1928

Authors

J F McIntosh1, E Möller, D D Van Slyke

Author Affiliations

1: Hospital of the Rockefeller Institute for Medical Research, New York.

Articles citing this

STUDIES OF UREA EXCRETION. II: Relationship Between Urine Volume and the Rate of Urea Excretion by Normal Adults. J Clin Invest (1928) 74.64

STUDIES OF UREA EXCRETION. IV: Relationship Between Urine Volume and Rate of Urea Excretion by Patients with Bright's Disease. J Clin Invest (1928) 49.42

STUDIES OF UREA EXCRETION. V: The Diurnal Variation of Urea Excretion in Normal Individuals and Patients with Bright's Disease. J Clin Invest (1928) 13.83

STUDIES OF UREA EXCRETION. IX. COMPARISON OF UREA CLEARANCES CALCULATED FROM THE EXCRETION OF UREA, OF UREA PLUS AMMONIA, AND OF NITROGEN DETERMINABLE BY HYPOBROMITE. J Clin Invest (1935) 12.78

The secretion of urine by newborn infants. J Physiol (1941) 12.71

BLOOD VOLUME IN CLINICAL SHOCK. II. THE EXTENT AND CAUSE OF BLOOD VOLUME REDUCTION IN TRAUMATIC, HEMORRHAGIC, AND BURN SHOCK. J Clin Invest (1946) 8.41

Gold Treatment in Rheumatoid Arthritis. Ann Rheum Dis (1945) 5.48

THE SIGNIFICANCE OF CONCENTRATION AND DILUTION TESTS IN BRIGHT'S DISEASE. J Clin Invest (1934) 4.73

A COMPARISON OF THE CREATININE AND UREA CLEARANCE TESTS OF KIDNEY FUNCTION. J Clin Invest (1933) 4.60

RENAL PLASMA FLOW AND SODIUM REABSORPTION AND EXCRETION IN CONGESTIVE HEART FAILURE. J Clin Invest (1948) 4.52

STUDIES OF UREA EXCRETION. VII THE EFFECTS OF POSTURE AND EXERCISE ON UREA EXCRETION. J Clin Invest (1932) 3.27

STUDIES OF THE KIDNEY IN ACUTE INFECTION: II. Observations with the Urea Clearance Test in Acute Rheumatic Infection. J Clin Invest (1931) 2.92

CLINICAL STUDIES WITH THE UREA-CLEARANCE TEST. Can Med Assoc J (1934) 2.29

THE EFFECT OF DIETARY PROTEIN ON THE UREA CLEARANCE OF CHILDREN WITH NEPHROSIS. J Clin Invest (1936) 2.03

Should clearance be normalised to body surface or to lean body mass? Br J Clin Pharmacol (1981) 1.93

STUDIES OF KIDNEY FUNCTION IN CHILDREN: I. Urea Clearance Values: (1) No Evidence of Kidney Disease (2) After Acute Hematuric Nephritis Following an Acute Infection (3) in the Acute Stage of Hematuric Nephritis. J Clin Invest (1935) 1.79

THE UREA CLEARANCE TEST IN TOXEMIAS OF PREGNANCY. J Clin Invest (1932) 1.59

ESTIMATION OF BLOOD VOLUME FROM CHANGE IN BLOOD SPECIFIC GRAVITY FOLLOWING A PLASMA INFUSION. J Clin Invest (1946) 1.59

Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) (2013) 1.51

The kidney in lead poisoning. Br J Ind Med (1961) 1.39

Body surface area as a determinant of pharmacokinetics and drug dosing. Invest New Drugs (2001) 1.35

Studies on VEM and VDM in blood in relation to renal hemodynamics and renal oxygen extraction in chronic congestive heart failure. J Clin Invest (1950) 1.20

THE EFFECT OF URINE VOLUME ON UREA EXCRETION. J Clin Invest (1947) 1.16

Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis (1992) 1.09

INCREASED UROBILINOGEN EXCRETION AND ACUTE HEMOLYTIC ANEMIA IN PATIENTS TREATED WITH SULFAPYRIDINE. J Clin Invest (1940) 1.08

THE RELATION OF HIGH AND LOW UREA CLEARANCES TO THE INULIN AND CREATININE CLEARANCES IN CHILDREN WITH THE NEPHROTIC SYNDROME. J Clin Invest (1941) 1.07

Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. Clin J Am Soc Nephrol (2008) 1.02

A COMPARISON OF THE UREA NITROGEN CONTENT OF CUTANEOUS AND VENOUS BLOOD BY MICRO GASOMETRIC ANALYSIS. J Clin Invest (1930) 1.02

GFR normalized to total body water allows comparisons across genders and body sizes. J Am Soc Nephrol (2011) 0.95

The assessment of glomerular function: creatinine clearance or plasma creatinine? Postgrad Med J (1978) 0.93

The renal circulation. Proc R Soc Med (1950) 0.90

Reflecting on 80 years of excellence. J Clin Invest (2004) 0.89

DIODRAST AND INULIN CLEARANCES IN NEPHROTIC CHILDREN WITH SUPERNORMAL UREA CLEARANCES. J Clin Invest (1943) 0.89

GLUCOSE EXCRETION IN BRIGHT'S DISEASE. J Clin Invest (1929) 0.83

KIDNEY FUNCTION DURING NORMAL PREGNANCY I. THE INCREASED UREA CLEARANCE OF NORMAL PREGNANCY. J Clin Invest (1935) 0.82

Escaping the correction for body surface area when calculating glomerular filtration rate in children. Eur J Nucl Med Mol Imaging (2008) 0.82

FACTORS WHICH DETERMINE RENAL WEIGHT : XI. RENAL FUNCTION. J Exp Med (1931) 0.76

Influence of Weight-Age Normalization on Glomerular Filtration Rate Values of Renal Patients: A STROBE-Compliant Article. Medicine (Baltimore) (2016) 0.75

Urea clearance tests. J Clin Pathol (1949) 0.75

Tests for Renal Function. Br Med J (1937) 0.75

Postnatal Maturation of the Glomerular Filtration Rate in Conventional Growing Piglets As Potential Juvenile Animal Model for Preclinical Pharmaceutical Research. Front Pharmacol (2017) 0.75

Normalization of glomerular filtration rate in obese children. Pediatr Nephrol (2016) 0.75

Articles by these authors

(truncated to the top 100)

STUDIES OF UREA EXCRETION. II: Relationship Between Urine Volume and the Rate of Urea Excretion by Normal Adults. J Clin Invest (1928) 74.64

STUDIES OF UREA EXCRETION. IV: Relationship Between Urine Volume and Rate of Urea Excretion by Patients with Bright's Disease. J Clin Invest (1928) 49.42

THE RELATIONSHIPS BETWEEN PLASMA SPECIFIC GRAVITY, PLASMA PROTEIN CONTENT AND EDEMA IN NEPHRITIS. J Clin Invest (1930) 32.28

THE EXCRETION OF ALBUMIN AND GLOBULIN IN NEPHRITIS. J Clin Invest (1927) 16.56

CARBOHYDRATE METABOLISM IN NEPHRITIS. J Clin Invest (1925) 11.77

STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46

THE CONCENTRATION OF THE PLASMA PROTEINS IN NEPHRITIS. J Exp Med (1924) 5.13

THE SIGNIFICANCE OF CONCENTRATION AND DILUTION TESTS IN BRIGHT'S DISEASE. J Clin Invest (1934) 4.73

PREPARATION OF HEMOGLOBIN SOLUTIONS FOR INTRAVENOUS INFUSION. J Exp Med (1947) 4.13

STUDIES OF LUNG VOLUME. I : RELATION BETWEEN THORAX SIZE AND LUNG VOLUME IN NORMAL ADULTS. J Exp Med (1918) 3.52

PROTEOSE INTOXICATIONS AND INJURY OF BODY PROTEIN : III. TOXIC PROTEIN CATABOLISM AND ITS INFLUENCE UPON THE NON-PROTEIN NITROGEN PARTITION OF THE BLOOD. J Exp Med (1918) 2.64

Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53

Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52

"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38

Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09

PLASMA LIPIDS IN CHRONIC HEMORRHAGIC NEPHRITIS. J Clin Invest (1936) 2.08

Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83

Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82

Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70

Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60

ESTIMATION OF BLOOD VOLUME FROM CHANGE IN BLOOD SPECIFIC GRAVITY FOLLOWING A PLASMA INFUSION. J Clin Invest (1946) 1.59

HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58

HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55

Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55

PREPARATION OF DRIED HEMOGLOBIN WITHOUT LOSS OF ACTIVITY. J Exp Med (1947) 1.50

Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48

Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48

Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46

A CONTRIBUTION TO THE RELATION BETWEEN PROTEID CLEAVAGE PRODUCTS AND ANAPHYLAXIS. J Exp Med (1913) 1.42

PLASMA LIPIDS IN ESSENTIAL HYPERTENSION. J Clin Invest (1936) 1.38

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36

Antigen binding cells in tolerant animals. Nature (1970) 1.35

In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32

Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32

Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31

B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27

The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23

Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21

HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20

STUDIES OF LUNG VOLUME : II. TUBERCULOUS MEN. J Exp Med (1918) 1.17

Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16

CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol (1993) 1.14

B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14

Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12

The Quantitative Influences of Certain Factors Involved in the Production of Cyanosis. Proc Natl Acad Sci U S A (1922) 1.12

Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11

Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10

Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol (1998) 1.08

The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07

B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07

HLA phenotypes and diabetic retinopathy. Diabetologia (1978) 1.06

HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol (1976) 1.04

Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci (1976) 1.04

Optimal conditions for polyclonal antibody secretion and DNA synthesis in human blood and spleen lymphocytes by lipopolysaccharide. Scand J Immunol (1978) 1.04

Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin. Clin Exp Immunol (1979) 1.03

The use of bacteria for the functional characterization of human lymphocyte subpopulations in various lymphoid organs. Scand J Immunol (1978) 1.03

Hydroxylysine formation from lysine during collagen biosynthesis. Proc Natl Acad Sci U S A (1966) 1.01

HLA-A,B,C and DR antigens in psoriasis. Tissue Antigens (1981) 1.00

Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. J Diabet Complications (1991) 1.00

Neutropenia and insufficiency of the exocrine pancreas. Acta Paediatr Scand (1967) 1.00

HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol (1985) 0.99

Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99

Unilateral, isometric bite force in 8-68-year-old women and men related to occlusal factors. Scand J Dent Res (1990) 0.99

Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol (1984) 0.97

Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells. Cell Immunol (1972) 0.96

The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96

Cytotoxic effects in vitro by lymphoid cells from specifically tolerant animals. Immunology (1969) 0.96

Tuberculous meningitis: immune reactions within the central nervous system. Scand J Immunol (1981) 0.95

HLA--determination in families with hereditary ataxia. Tissue Antigens (1978) 0.95

Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol (1996) 0.94

HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94

Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurol Scand (1979) 0.92

High incidence of spontaneous Ig-producing lymphocytes in peripheral blood and synovial fluid of patients with active seropositive rheumatoid arthritis. Scand J Immunol (1982) 0.92

Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation (1996) 0.91

Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis (1996) 0.91

RENAL EFFECTS OF HEMOGLOBIN INFUSIONS IN DOGS IN HEMORRHAGIC SHOCK. J Exp Med (1947) 0.91

Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol (1977) 0.91

Studies on the major histocompatibility system in patients with ankylosing spondylitis. Tissue Antigens (1975) 0.90

Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90

Identification of five lymphocyte activating determinants in man. Tissue Antigens (1975) 0.90

Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol (1975) 0.90

Considerations of some current concepts in cancer research. J Natl Cancer Inst (1975) 0.89

Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo. Scand J Immunol (1984) 0.89

HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens (1984) 0.89

Antigen-binding cells in immune and tolerant animals. Transplant Rev (1972) 0.87

The continuing carrier problem. Transplant Rev (1974) 0.87

STUDIES OF GAS AND ELECTROLYTE EQUILIBRIA IN THE BLOOD : IX. THE DISTRIBUTION OF ELECTROLYTES BETWEEN TRANSUDATES AND SERUM. J Gen Physiol (1927) 0.87

[Immunoglobulin E in allergic bronchial asthma with special reference to the most important inhalation antigens]. Dtsch Med Wochenschr (1972) 0.87

Interleukin 4 and interferon gamma production in restimulated CD4+ and CD8+ cells indicates memory type responsiveness. Scand J Immunol (1991) 0.87

Antigenic markers on mouse lymphoid cells: origin of cells mediating immunologic memory. Cell Immunol (1973) 0.87

A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum (1988) 0.87

Psoriasis, sacro-iliitis and peripheral arthritis occurring in patients with the same HLA haplotype. A preliminary family report and a hypothetical explanation of the interaction between MHS products. Tissue Antigens (1976) 0.87

Cytokines in rheumatoid arthritis. Ann Med (1991) 0.87

The determination of gases in blood and other solutions by vacuum extraction and manometric measurement. I. J Biol Chem (2002) 0.86

Inhibition of the Fc receptor of human lymphoid cells by antisera-recognizing determinants of the hla system. J Exp Med (1976) 0.86

HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations. Tissue Antigens (1979) 0.86

Follow-up of children of insulin dependent (type I) and gestational diabetic mothers. Growth pattern, glucose tolerance, insulin response, and HLA types. Acta Paediatr Scand (1984) 0.86

Specificity of hapten-reactive T and B mouse lymphocytes. Affinity and avidity of T- and B-cell receptors and anti-hapten antibodies as factors of dose and time after immunization. Scand J Immunol (1974) 0.86

Mitogenic properties of rabbit anti-human beta 2-microglobulin for murine B cells. Scand J Immunol (1974) 0.86

Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol (2002) 0.85